therefore, regular foot examinations are recommended for patients with diabetes at least annually to identify risk factors for ulceration and amputation
LY3437943, a novel triple GIP, GLP-1, and glucagon receptor agonist for glycemic control and weight loss
GLP-1RAs are overall well-tolerated, with their most common adverse effects being nausea, vomiting, and diarrhea [7]
Long-term unknowns: We do not have safety data for decades of low-dose GLP-1 use in otherwise healthy, lean athletes
Axonal Recovery Regenerates nerves, promotes neural function, and protects neurons
This is often mistaken for GLP-1 medication fatigue when it is actually a consequence of inadequate protein and muscle preservation